Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Periradicular infiltration for sciatica: a randomized controlled trial. (University Hospital of Oulu, Helsinki, Finland). Spine. 2001;26:1059–1067.

Periradicular infiltration for sciatica: a randomized controlled trial. (University Hospital of... In this study, 160 consecutive, eligible patients with sciatica who had unilateral symptoms of 1 to 6 months duration, and who never underwent surgery were randomized for a double‐blinded injection with methylprednisolone bupivacaine combination or saline. Objective and self‐reported outcome parameters and costs were recorded at baseline, at 2 and 4 weeks, at 3 and 6 months, and at 1 year. Recovery was better in the steroid group at 2 weeks for leg pain, straight leg raising, lumbar flexion, and patient satisfaction. Back pain was significantly lower in the saline group at 3 and 6 months. Sick leave and medical costs were similar for both treatments, except for cost of therapy visits and drugs at 4 weeks, which were in favor of the steroid injection. By 1 year, 18 patients in the steroid group and 15 in the saline group underwent surgery. Conclude improvement during the follow‐up was found in both the methylprednisolone and saline groups. The combination of methylprednisolone and bupivacaine seems to have a short‐term effect, but at 3 and 6 months, the steroid group seems to experience a “re‐bound” phenomenon. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pain Practice Wiley

Periradicular infiltration for sciatica: a randomized controlled trial. (University Hospital of Oulu, Helsinki, Finland). Spine. 2001;26:1059–1067.

Download PDF
16 pages

Loading next page...
 
/lp/wiley/periradicular-infiltration-for-sciatica-a-randomized-controlled-trial-5Tb6xeI1BS

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
Copyright © 2001 Wiley Subscription Services
ISSN
1530-7085
eISSN
1533-2500
DOI
10.1046/j.1533-2500.2001.1039_49.x
Publisher site
See Article on Publisher Site

Abstract

In this study, 160 consecutive, eligible patients with sciatica who had unilateral symptoms of 1 to 6 months duration, and who never underwent surgery were randomized for a double‐blinded injection with methylprednisolone bupivacaine combination or saline. Objective and self‐reported outcome parameters and costs were recorded at baseline, at 2 and 4 weeks, at 3 and 6 months, and at 1 year. Recovery was better in the steroid group at 2 weeks for leg pain, straight leg raising, lumbar flexion, and patient satisfaction. Back pain was significantly lower in the saline group at 3 and 6 months. Sick leave and medical costs were similar for both treatments, except for cost of therapy visits and drugs at 4 weeks, which were in favor of the steroid injection. By 1 year, 18 patients in the steroid group and 15 in the saline group underwent surgery. Conclude improvement during the follow‐up was found in both the methylprednisolone and saline groups. The combination of methylprednisolone and bupivacaine seems to have a short‐term effect, but at 3 and 6 months, the steroid group seems to experience a “re‐bound” phenomenon.

Journal

Pain Practice – Wiley

Published: Jan 1, 2001

There are no references for this article.